Showing results (31-40 of 67) with videos related to
Sort By:
Pageof 7
Oncotarget|June 25, 2019
Multidisciplinary palliation for unresectable recurrent rectal cancer: hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort studyStefano Guadagni, Giammaria Fiorentini, Andrea Mambrini, et al.Pharmacogenomics|October 27, 2011
Association between DNA-repair polymorphisms and survival in pancreatic cancer patients treated with combination chemotherapyElisa Giovannetti, Paola Pacetti, Michele Reni, et al.In Vivo (Athens, Greece)|January 6, 2007
Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: results of a multi-centric randomized studyGiammaria Fiorentini, Maurizio Cantore, Susanna Rossi, et al.Journal of Pain and Symptom Management|August 7, 2013
Use and perceived benefits of complementary therapies by cancer patients receiving conventional treatment in ItalyAndrea Bonacchi, Lorenzo Fazzi, Alessandro Toccafondi, et al.World Journal of Clinical Oncology|July 3, 2023
Hyperthermia combined with chemotherapy vs chemotherapy in patients with advanced pancreatic cancer: A multicenter retrospective observational comparative studyGiammaria Fiorentini, Donatella Sarti, Andrea Mambrini, et al.Plos One|September 20, 2014
AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patientsAbolfazl Avan, Amir Avan, Tessa Y S Le Large, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 4, 2010
Treatment trends in metastatic pancreatic cancer patients: Is it time to change?Michele Reni, Lara Maria Pasetto, Alessandro Passardi, et al.Anti-Cancer Drugs|January 30, 2010
An Italian study on treatment trends and outcomes of patients with stage III pancreatic adenocarcinoma in the gemcitabine era: is it time to change?Michele Reni, Nora Sartori, Andrea Mambrini, et al.European Journal of Cancer (Oxford, England : 1990)|August 1, 2013
Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: a phase II randomised trialMichele Reni, Stefano Cereda, Michele Milella, et al.World Journal of Gastrointestinal Oncology|June 20, 2015
Locoregional therapy and systemic cetuximab to treat colorectal liver metastasesGiammaria Fiorentini, Camillo Aliberti, Donatella Sarti, et al.Pageof 7